Categories AlphaGraphs, Earnings, Health Care

ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while revenues missed. The company also provided guidance for fiscal 2022.

AbbVie Q3 2022 earnings infographic

Total revenues increased 3.3% year-over-year to $14.81 billion, aided by a strong performance by the immunology and neuroscience segments. But the top line missed the Street view.

At $3.66 per share, adjusted net income was sharply higher than the $2.83 per share profit reported in the prior-year period, and above the consensus forecast. Third-quarter unadjusted profit increased to $3.95 billion or $2.21 per share from $3.18 billion or $1.78 per share in the third quarter of 2021.

Check this space to read management/analysts’ comments on AbbVie’s Q3 2022 earnings

“We continue to see strong momentum from our key immunology assets, Skyrizi and Rinvoq, and this performance – combined with strength from other growth drivers within our diverse portfolio – has mitigated the impact of temporary economic headwinds on our aesthetics products to deliver another quarter of strong results,” said Richard A. Gonzalez, CEO of AbbVie.

Prior Performance

  • Abbvie Q2 2022 earnings infographics
  • AbbVie Q3 2021 earnings infographic

Most Popular

MKC Earnings: Key quarterly highlights from McCormick & Company’s Q1 2023 financial results

McCormick & Company, Incorporated (NYSE: MKC) reported first quarter 2023 earnings results today. Sales increased 3% year-over-year to $1.56 billion. Sales growth was 5% in constant currency. Net income was $139.1

Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company's full-year net loss narrowed from the prior year.

Can KB Home (KBH) beat market headwinds in 2023?

KB Home (NYSE: KBH) has been expanding its presence beyond the key markets lately, while also diversifying homebuilding operations by offering highly customized options to customers. The downturn in the

Add Comment
Viewing Highlight